Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
KANZHUN LIMITED repurchased RMB74 million ordinary shares under its repurchase plan
-
Leading Proxy Advisor ISS Recommends Medallion Shareholders Vote “FOR” Both of the Board’s Director Nominees on the BLUE Proxy Card
-
Agrify Corporation Regains Compliance with Nasdaq Stockholders’ Equity Requirement
-
Judge Consulting Recognized on 2024 CRN Solution Provider 500 List
-
Venus Concept Announces $35 million Debt-to-Equity Exchange Transaction
-
Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
-
PGS ASA: Calling Notice for 2024 Annual General Meeting
-
Clene Provides Update on Its NIH-Funded Expanded Access Program for CNM-Au8® in ALS (ACT-EAP)
-
LEGAL DEADLINE ALERT: Sprout Social (Nasdaq: SPT) Investors are Encouraged to Contact BFA Law before July Deadline in Securities Class Action after Stock Tumbled Over 40%
-
CEREVEL THERAPEUTICS ALERT: Cerevel’s $45 Merger Offer From AbbVie is Under Investigation (Nasdaq: CERE) – Contact BFA Law to Discuss How this Impacts You
-
Atrion Corporation Enters Into Merger Agreement with Nordson Corporation
-
Royalty Pharma and Agios Pharmaceuticals Enter Into Vorasidenib Royalty Agreement for $905 Million
-
Gold Royalty Announces Agreement to Acquire Vares Copper Stream
-
Gold Royalty Announces US$30 Million Bought Deal Financing
-
Invesco Ltd: Form 8.3 - BHP Group Ltd. Public dealing disclosure
-
Key information relating to the cash dividend to be paid by Golar LNG Limited (Ticker: GLNG)
-
Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress
-
Golar LNG Limited Interim results for the period ended March 31 2024
-
Olema Oncology to Participate in Upcoming Investor Conferences in June
-
Ocugen Set to Join Russell 3000® Index Effective June 28, 2024
-
Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria
-
New Opportunity for the Wilson Project
-
CAA Worst Roads Campaign Reaffirms Growing State of Good Repair Backlog and Need for Municipal Funding
-
Angus Gold Makes New Gold Discovery on Golden Sky Project, Wawa; Eagle River Splay Target Returns 5.4 metres of 2.0 g/t Au
-
Breaking period stigmas: SOGC marks World Menstrual Hygiene Day championing access to affordable period products, open dialogue
-
Forsys Reports Interim Drilling Results at Norasa
-
West Red Lake Gold Announces Listing of Warrants
-
Major Drilling to Release Fourth Quarter and Fiscal 2024 Results
-
Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management
-
Agios Announces $905 Million Purchase Agreement for Vorasidenib Royalty
-
Presenting on the Emerging Growth Metals Mining Resources & Energy Conference on May 29 Register Now
-
Nevada Exploration Forms Advisory Board and Appoints Former Uranerz Uranium Professionals
-
Alpine Income Property Trust Declares Dividend For the Second Quarter 2024
-
CTO Realty Growth Declares Dividends For the Second Quarter 2024
-
Treace to Present at Truist Securities MedTech Conference
-
Actuate Therapeutics Files Registration Statement for Initial Public Offering
-
Eclipse Foundation and the Adoptium Working Group Announce Latest Eclipse Temurin Open Source Java SE Release
-
BioXcel Therapeutics to Present at Jefferies Global Healthcare Conference
-
Telix Submits NDA for New Prostate Cancer Imaging Agent
-
Nurix Therapeutics Appoints Paula G. O’Connor, M.D., as Chief Medical Officer and Pasit Phiasivongsa, Ph.D., as Chief Technical Officer
-
Aruna Bio to Present at BIO International Convention 2024
-
Mobilicom Secures Another Follow-On Order from the U.S. Defense Industry
-
Atha Energy Agrees to Terms on $10.7 Million Option Agreement with Riverboat Energy Corporation for Vista Project
-
Sol-Gel Announces Receipt of Nasdaq Minimum Price Notice
-
Orion Group Holdings Set to Join the Russell 3000® Index
-
Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Psychopharmacology Annual (ASCP) Meeting
-
Merus’ Petosemtamab in Combination with Pembrolizumab Interim Data Demonstrates Robust Response Rate and Favorable Safety Profile in 1L r/m HNSCC
-
9thCO Crafts Next.js-Powered Online Marketplace for Travel Startup RollDeep
-
Ocean Power Technologies Completes Operation with Multiple Unmanned Surface Vehicles for US Government
-
Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June

